Thus, while NAOV was the star of the day in the sector, the residual opportunities could be just as lucrative to
SNWV intends to follow a similar course of marketing, intending to make WoundShield® available to the massive pain relief treatment. It adds to its dermaPACE® and UltraMIST® shockwave lineup, and will capitalize on additional market opportunities and add new revenue streams. Better still, SNWV is in the process of creating those streams now, seeking regulatory approval of WoundShield® in
By the way,
Bullish Shockwave Markets
In fact, SNWV is decidedly bullish on the revenue-generating opportunities inherent to its WoundShield® license. Commenting on the agreement earlier this year, Kevin A. Richardson II, Chairman of the Board and CEO of
The
Accretive Value In A Valued Sector
And that's potentially excellent news for
SANUWAVE Asset Portfolio Stronger Than SOLY
Indeed, ABBV helped change the narrative on the value of shockwave technology. And while they purchased SOLY, which has one device, know that SNWV already has TWO FDA-cleared shockwave technology devices in the market.
And not only are its devices already commercialized, but they also drove record-setting revenue in its latest Q-report, earned an additional 11 patients in the past fifteen months, and extended its reach by developing several international markets. Considering those advantages compared to a non-revenue generating SOLY device,
Now, with
Value Could Soar After Filings
And its consolidation in a tight trading range may be exposing a compelling value opportunity. However, after they get filings current, expect the deals accrued over the past six months to profoundly impact its share price. In fact, getting those done is likely the milestone investors are waiting for.
Once that happens, AbbVie's bid to set a high valuation bar for companies in the shockwave sector, along with interest given to this morning's
Best of all, with SNWV only a report away from being compliant, gains could come sooner rather than later.
Disclaimers: Hawk Point Media is responsible for the production and distribution of this content. Hawk Point Media is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by Hawk Point Media is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall Hawk Point Media be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by Hawk Point Media, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Hawk Point Media strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Hawk Point Media was compensated up to
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
Media Contact
Company
Contact Person:
Email: info@hawkpointmedia.com
Phone: 3057806988
City:
State:
Country:
Website: https://www.sanuwave.com
.
(C) 2021 M2 COMMUNICATIONS, source